Osaka, Japan

Hironori Yamashita


 

Average Co-Inventor Count = 3.3

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2017-2018

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Hironori Yamashita: Innovator in Pharmaceutical Chemistry

Introduction

Hironori Yamashita is an accomplished inventor based in Osaka, Japan, recognized for his significant contributions to the field of pharmaceutical chemistry. With a total of two patents to his name, he has made strides in developing methods and compounds that hold promise for treating various health conditions.

Latest Patents

Yamashita's latest patents include a groundbreaking method for producing heterocyclic compounds, particularly useful as prophylactic or therapeutic drugs for diabetic nephropathy, hypertension, and related ailments. The production method involves reacting specific compounds in the presence of an aluminum compound and a chiral amine compound. Additionally, he has developed free base crystals of a complex imidazo-pyrazolo-pyrimidinone compound, along with methods for their creation and application.

Career Highlights

Throughout his career, Hironori Yamashita has worked for well-known companies, including Takeda Pharmaceutical Company Limited and Intra-Cellular Therapies, Inc. His work in these organizations has significantly impacted the development of innovative treatments in the pharmaceutical industry, further establishing his reputation as a leading inventor.

Collaborations

Collaboration is a key aspect of Yamashita's journey as an inventor. He has worked alongside notable colleagues such as Kazuhiro Miwa and Takashi Abe, contributing to projects that advance scientific understanding and therapeutic options in medicine.

Conclusion

Hironori Yamashita's contributions to pharmaceutical chemistry exemplify the crucial role that inventors play in developing innovative solutions to medical challenges. His work not only reflects his expertise but also highlights the importance of collaboration in advancing science and improving patient care.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…